New COVID-19 drug enters human testing phase
NCT ID NCT07157007
Summary
This study is testing a new oral medication called ratutrelvir, given alongside standard COVID-19 treatment, in adults with mild to moderate symptoms. The main goals are to find a safe and effective dose and to see how well it helps people recover from COVID-19 symptoms. About 90 participants who test positive and have had symptoms for less than 5 days will take the study drug at home.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Chang Gung Memorial Hospital, Linkou Branch
NOT_YET_RECRUITINGTaoyuan District, Taoyuan, 333, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Chonnam National University Hospital
NOT_YET_RECRUITINGGwangju, Donggu, 61469, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hallym University Sacred Heart Hospital Gangnam
NOT_YET_RECRUITINGSeoul, Seoul, 07441, South Korea
Contact Email: •••••@•••••
-
Inha University Hospital
NOT_YET_RECRUITINGIncheon, Jung-gu, 22332, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kaohsiung Medical University Hospital
NOT_YET_RECRUITINGKaohsiung City, Kaohsiung, 807, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Key Health
RECRUITINGSydney, New South Wales, 2000, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Momentum Clinical Research Taringa
RECRUITINGBrisbane, Queensland, 4068, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Novatrial
RECRUITINGCharlestown, New South Wales, 2290, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Paratus Clinical(Clinical Trials Institute, Torquay)
NOT_YET_RECRUITINGTorquay, Victoria, 3228, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Research Institute of Virology
RECRUITINGTashkent, Tashkent, 100194, Uzbekistan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Taichung Veterans General Hospital
NOT_YET_RECRUITINGTaichung, Taichung, 407, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Taipei Medical University Hospital
NOT_YET_RECRUITINGTaipei, Taipei, 110, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Taoyuan General Hospital
NOT_YET_RECRUITINGTaoyuan District, Taoyuan, 33004, Taiwan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The Catholic University of Korea, Eunpyeong St. Mary's Hospital
NOT_YET_RECRUITINGSeoul, Eunpyeong-gu, 07441, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Wonju Severance Christian Hospital
NOT_YET_RECRUITINGWŏnju, Gangwon-do, 26426, South Korea
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.